atrasentan has been researched along with Cardiovascular Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Aubert, JD; Juillerat-Jeanneret, L | 1 |
Abdelhady, SA; Darwish, IE; El-Deeb, NM; El-Mas, MM; Gowayed, MA; Habib, YH | 1 |
Parving, HH; Rossing, P | 1 |
Brunner, F; Kirchengast, M; Pang, X; Stessel, H; Wölkart, G | 1 |
1 review(s) available for atrasentan and Cardiovascular Diseases
Article | Year |
---|---|
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis.
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Endothelin Receptor Antagonists; Fibrosis; Humans; Hypertension, Pulmonary; Neoplasms; Receptors, Endothelin | 2016 |
3 other study(ies) available for atrasentan and Cardiovascular Diseases
Article | Year |
---|---|
Modulation by antenatal therapies of cardiovascular and renal programming in male and female offspring of preeclamptic rats.
Topics: Animals; Atrasentan; Cardiovascular Diseases; Disease Models, Animal; Endothelin A Receptor Antagonists; Female; Kidney Diseases; Male; Methyldopa; Naphthalenes; NG-Nitroarginine Methyl Ester; Pre-Eclampsia; Pregnancy; Prenatal Care; Propionates; Rats; Receptors, Thromboxane A2, Prostaglandin H2; Sex Factors; Sympatholytics | 2021 |
Diabetic nephropathy in 2014: improved cardiorenal prognosis in diabetic nephropathy.
Topics: Atrasentan; Cardiovascular Diseases; Diabetic Nephropathies; Endothelin Receptor Antagonists; Humans; Prognosis; Pyrrolidines | 2015 |
Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Female; Fibrosis; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Oxidative Stress; Pyrrolidines; Ramipril; Rats; Rats, Sprague-Dawley; Streptozocin; Ventricular Function, Left; Ventricular Pressure | 2007 |